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Background & objectives : Malaria is the most widespread parasitic disease in sub-Saharan Africa
with associated high morbidity and mortality especially among the highly predisposed population of
pregnant women and children of age five years and below. Living in malaria endemic regions of the
world has become associated with health and economic hazards placing financial and productive
burden on affected households.
Methods: A prospective study of children treated for malaria and other associated illnesses at a
Nigeria tertiary health institution between May and October 2003 was undertaken. The various malaria-
associated diseases treated were determined from their provisional diagnosis, hospital records and
causative agents confirmed from their diagnostic laboratory results. Cost of treatment was determined
from the patients’ guardian and confirmed from relevant hospital departments. Common drugs for
malaria treatment, their costs, relative effectiveness and frequency of use were determined through a
completed questionnaire by health officers and patients’ guidance.
Results: Of 5356 paediatric patients suspected of having malaria, 5100 (95.2%) were confirmed positive
for malaria parasites microscopically. Of these, 4119 (80.8%) were aged 0 – 6 years, with children aged
1 to 3 years being mostly affected. Eight hundred and twenty (16.1%) of them were in-patients
spending an average of six days on hospital bed. Over 22 million naira ($ 0.22 m) was spent on the
treatment of malaria with drugs accounting for the major cost (66.81%). About 33.7% of the patients
had malaria complicated with other diseases.
Interpretation & conclusion: The effectiveness of common therapeutic agents used for malaria
treatment, their costs and associated side effects is discussed. Recommendations are made for
appropriate care and government subsidy for paediatric malaria management in sub-Saharan  Africa.
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Malaria is the most prevalent infectious disease in sub-
Saharan Africa. WHO1 estimated approximately 300–
500 million annual cases of malaria world over, with
90% of this number in sub-Saharan Africa, resulting in
1.5–3.5 million deaths. Mortality is predominantly
among children of age five years and below2. In Nigeria,
malaria is directly responsible for over 1,00,000
deaths of children below school age and one quarter
of an average family income is spent on the treatment
of malaria3. The malaria burden is further com-
pounded by abundant vectorial system of the
anopheline mosquito vector and its increasing insecti-
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cide resistance. The increasing wave of the parasite
resistance to current antimalaria drugs has made mat-
ters worse4.
Malaria obstructs overall economic development in Af-
rica. It contributes significantly to hurting the living stan-
dards of Africans and impedes the improvement of the
living standard of future generations by its debilitating
effects. Funds meant for development are channeled
annually into provision of malaria drugs, bednets and in-
secticides. Africa’s gross domestic product (GDP) is
reduced by over $100 billion by the disease1.
In malaria endemic areas children suffer an average of
six bouts of the disease yearly making it the most com-
mon cause of school absenteeism5. At least, one third
of primary school children in endemic rural areas miss a
week of school time due to the disease6. Anaemia is an
inevitable consequence of malaria infections in children
and pregnant women, accounting for 30% of prevent-
able low birth weights among newborn infants, under-
mining their growth and development6.
The present study is a prospective investigation of the
epidemiology, therapeutic agents used for treatment
and management cost of paediatric malaria at the Abia
State University Teaching Hospital, Aba. It is aimed at
determining some demographic risk factors, common
associated diseases, and relative cost of diagnosis and
treatment of paediatric malaria.
Material & Methods
Study area: The study was carried out at the Abia
State University Teaching Hospital, Aba. Aba is lo-
cated in Abia State, Eastern Nigeria. It consists of five
local government areas. Aba city is located between
latitude 5o8’N and longitude 7o20’N. It is tropical in
climate with a relief of about 0–200 ft  (0–61 m)
above the sea level and mean annual temperatures
range from 25.5–26.5oC. It has a wet/raining season
(April–early October) and a dry season (late Octo-
ber–March) with peak raining period in June/July.
Maximum annual rainfall is 2250–2500 mm. The
mean relative humidity is 80%. The population density
is about 2000 persons/km2.
Study design: The study was designed to obtain rel-
evant demographic data, diagnostic laboratory results,
drugs and other medications administered and the cost
of paediatric malaria management of patients aged 12
years and below suspected of malaria and malaria re-
lated illnesses in the hospital between May and October
2003. Investigations were done routinely using standard
diagnostic methods. Care types were registered under
in-patients, out-patients and children emergency. Data
collected from patients and/or patients’ records were
age, care type, duration of hospital stay, investigations
carried out, drugs administered and amount expended
at various departments/units in the hospital on treatment
folder/receipts at the medical records. Patients without
complete records were excluded from the study.
Medical laboratory results were used to confirm clini-
cal provisional diagnosis of consulting physicians. Ma-
laria parasites were investigated using thick and thin
blood films and results recorded by the methods of
Bruce-Chwatt7 and Olsen et al 8. Haematocrit, total
and differential leucocytes counts were done using
Bain’s method in Dacie and Lewis9. Anaemia was
confirmed with a haematocrit value of 25% and below
in the study. Urinary tract infections (UTI), upper res-
piratory tract infection, enteric fever, gastroenteritis
and otitis media were confirmed by culture methods,
while subcultures were identified using standard bac-
teriological techniques as described by Mackie and
McCartney10. Antibiodisc susceptibility was carried
out by multidisc technique as described by Stokes and
Ridgwey11. Amoebiasis and helminthiasis were con-
firmed in stool by direct saline smear and stool con-
centration was carried out by formal ether concentra-
tion techniques12. Jaundice was confirmed by serum
and urine bilirubin and viral hepatitis ruled out using
hepatitis B and C antigen-antibody reaction kits of
Randox Laboratories Inc13.
Detailed questionnaires prepared for the purpose
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agents used by health officers and patients, their effec-
tiveness, costs and associated side effects.
Statistical analysis: Simple percentages, mean
scores, histograms and c2 were used to depict the
statistical significance of results obtained in the study.
Results
A total of 5766 children aged 12 years and below
clinically suspected of malaria fever were examined, of
these 5356 children had complete records and were
used for this study. Out of the 5356 children clinically
suspected and examined for malaria, 5100 (95%)
were microscopically confirmed malaria cases [2439
(47%) males and 2661 (53%) females]. The health
point prevalence rate of malaria for the age bracket
0–12 years in the hospital was 95%. Fig. 1 shows the
paediatrics malaria intensity in the study.
Table 1 shows other paediatric malaria related disease
conditions in the study. Anaemia was found to be the
Table 1. Other diseases/conditions associated with paediatric malaria
Disease           No. infected/            No.  uninfected (%)         c2 p-value
         affected (%)
Urinary tract  infections (UTI) 162 (3) 5194 (97) 4.85 > 0.05
Anaemia 689 (12.86) 4667 (87.14) 74.67 < 0.01
Upper respiratory tract 105 (1.96) 5251 (98.04) 7.19 = 0.05
  infections/Pneumonia
Gastroenteritis 168 (3.14) 5188 (96.86) 7.37 = 0.05
Enteric fever 193 (3.6) 5163 (96.4) 13.59 > 0.05
Helminthiasis 213 (3.98) 5143 (96.03) 33.2 < 0.05
Bacterial skin infection 45 (0.84) 5311 (99.16) 15.2 > 0.05
Jaundice 28 (0.52) 5328 (99.48) 6.1 > 0.05
Amoebiasis 67 (1.25) 5289 (98.75) 35.2 < 0.05
Otitis media 34 (0.64) 5322 (99.36) 12.1 > 0.05
Dysponea 6 (0.056) 5350 (99.89) 3.5 > 0.05
Asthma 6 (0.056) 5350 (99.89) 3.5 < 0.05
Oral thrush 6 (0.056) 5350 (99.89) 3.5 < 0.05
Total 1722 (100)
Fig. 1: Intensity of malaria parasites in the study
+ = 10 parasites per 100 thick film fields; ++ = 100
parasites per 100 thick film fields; +++ = 10 parasites
per one thick film fields; and ++++ = more than parasites
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most serious and prevalent condition associated with
paediatric malaria with a prevalence of 12.86%.  This
was followed by helminthiasis (3.98%), enteric fever
(3.6%), gastroenteritis (3.14%), and urinary tract in-
fection (3%). Others include upper respiratory tract
infection/pneumonia (1.96%), amoebiasis (1.25%),
bacterial skin infections (0.84%), otitis media (0.64%)
and jaundice (0.52%). Dyspnoea, asthma and oral
thrush were each 0.056%.
Fig. 2 shows the age related distribution of paediatric
malaria in the study. More than 50% of infection rates
were at the age bracket 1–3 years, the age bracket
4–6 years followed these with 20.1% of infections re-
corded. The age groups 0–1 and 7–9 years were both
16.5% and 10–12 years were 8.7% respectively. The
mean age of the affected children was 3.12 ± 2.99
(Table 2).
Naira were expended by 5356 children for treating ma-
laria and malaria related illnesses over a period of six
months in the study area (Table 3).
A total of 4280 patients were treated as out-patients,
and 642 (15%) of this number were noted to have re-
jected being admitted on account of lack of funds. In all
820 children were treated as in-patients spending a to-
tal of 4500 days in hospital with a mean hospital stay of
5.5 days. In-patients attracted an average additional fee
of 1,350 Naira per patient. The hospital charged a pro-
fessional fee/indirect cost of 500 Naira on prolateral
basis for treating children as out-patients (Table 3).
Fig. 3 shows the common therapeutic agents used for
malaria treatment in the area. Chloroquine sulphate
was the most common drug in use in the area. It also
had the highest cases of parasites resistance and treat-
ment failure in the course of the study. This was fol-
lowed by quinine hydrochloride, which was mainly giv-
en to in-patients as quinine drip. The pyrimethamine/
Fig. 2: Age distribution of paediatric malaria patients
The present investigations showed that drugs accounts
for > 66.8% of the cost of malaria treatment in the area
with 14.71 million Naira. Medical laboratory analysis
accounted for 15.5% amounting to 3.42 million Naira
and professional fees 11.6% accounting for 2.5 million
Naira. Hospital bill (in patients) was 5% accounting for
1.11 million Naira and blood transfusion was 1.1%
amounting to 0.24 million Naira. A total of 22 million
Table 2. Care type, age and sex  distribution of patients
Distribution of patients Male Female Total
Age in yr (mean ± SD) 3.16 ± 2.9 3.08 ± 3 3.12 ± 2.99
Number of out-patients 2130 2150 4280
Number on admission 390 430 820
Admission duration (days) 2430 2070 4500
Table 3. Cost of malaria treatment
Bill /Headings Amount in Naira (%)
Drugs 14,709,500 (66.8)
Laboratory analysis 3,417,000 (15.5)
Professional fee/indirect cost 2,550,000 (11.6)
 (at 500 Naira per out-patient)
Hospital bill (in-patients) 1,107,540 (5)
Blood transfusion (in-patients)  235,385 (1.1)
Total 22,019,425 (100)
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sulphadoxine  preparations were next most commonly
used followed by the amodiaquine. Halfan (halo-fan-
trine) was mostly given to children aged 0–3 years as
syrups, while chloroquine preparations were often
combined and/or supplemented by pyrimethamine/sul-
phadoxine preparations as malwin, amalar and maldox
tablets. Cotecxin (artemisinin) was the least pre-
scribed drugs from the hospital pharmacy antimalaria
drugs list on the basis of cost. Fig. 4 shows that cost
was the most important consideration for paediatric
malaria treatment in the hospital. This was followed by
effectiveness and side effects in that order.
Discussion
Malaria is holoendemic in Nigeria. Various factors are
known to contribute to the endemicity of the disease
in the study area. These include the ever-deplorable
conditions of Aba urban with refuse heaps in and
around dust bins, littered around major street junc-
Fig. 3: Common therapeutic agents used in the study area for malaria treatment
A= Chloroquine (Chloroquine sulphate); B = Quinine (Quinine hydrochloride); C = Fansidar (Sulphadoxine/
pyrimethamine); D = Maloxine (Sulphadoxine/pyrimethamine); E = Cotecxine (Artimisinin); F = Camoquine
(Amodiaquine); G = Halfan (Halofantrine); H = Amalar (Sulphadoxine/pyrimethamine); I = Malwin
(Sulphadoxine/pyrimethamine)
Fig. 4: Cost benefit relationship of common drugs used in the
study areaJ  VECT  BORNE  DIS  42, SEPTEMBER  2005 92
tions, becoming breeding sites for mosquito malaria
vectors. Blocked drainages, and domestic water stor-
age facilities contribute to malaria vector abundance in
the study area. Further into the suburban areas, mos-
quito breeding sites are superfluous with ponds,
puddles, domestic water storage facilities and bushy
surroundings of living homes forming suitable breeding
sites for mosquito vectors.
The Abia State University Teaching Hospital as a ter-
tiary hospital serves as a referral centre for patients
both from the urban and suburban areas referred from
hospitals and health centres in these areas and also it is
a resort by patients who chose to come directly to it
for purpose of benefiting from its available manpower
and facilities.
The health point prevalence of malaria in this study is
95% with a mean infected age of 3.12 ± 2.09 years.
This is  expected as the hospital is a reference centre
with convergence of sick children who may have been
treated at home, chemist shops or referred from other
hospitals. Furthermore investigation and treatment for
malaria is a first line of management for paediatrics in
Nigerian health centres. The health point prevalence in
this study represents the positive blood smear among
investigated children is slightly higher than the crude
parasite rates reported by Salako14 among pre-school
age children in parts of Western Nigeria. This is ex-
pected as malaria is the major cause of hospital atten-
dance in Nigeria, hence higher infection rates are ex-
pected for the children within the age group under
study. However, the results confirm a higher parasites
rate among pre-school children (below 6 years) as re-
ported by Salako14 and Stanley2.
Plasmodium falciparum was the parasite reported in
98% of the cases found in the study. The parasites in-
tensity reported in the study was +, ++ and +++ in
that order. This is also similar to the gametocyte rates
found in the study. Low parasite counts are often due
to ineffective treatment and/or treatment failure as
most parents only resort to hospital when they cannot
bring the treatment under control. Lack of funds, poor
human development index and a poorly developed
health system may be accountable for the resort to
self-medication by such parents. There was no signifi-
cant sex-related distribution of infected children in this
study. This confirms earlier reports by Stanley2 and
Salum et al15. Anaemia accounts for 40.1% of the se-
rious conditions associated with malaria in this study.
Anaemia is known to be the major cause of death in
paediatric malaria especially among children with hae-
moglobin AA and more precarious are those with hae-
moglobin SS. In heavy infections, haematocrit of in-
fected children may be reduced by 10% over a 24-
hour duration where the treatment failed and/or where
proper management was not given. Enteric fever and
helminthiasis were compromising conditions among
older children of age 6–12 years.
The economic cost of malaria in the study area is high
especially on low income earning families as most chil-
dren have a range of 2–6 bouts of the disease a year
with an average of four bouts, this confirms that ma-
laria is a major cause of school absenteeism in sub-
Saharan Africa6. In our study, an average cost of man-
aging a bout of the disease was 3,800 Naira for out-
patients and 4,700 Naira for in-patients, this could be
more if blood transfusion is required. The minimum in-
come earning capacity of a Nigerian worker is 6,000
Naira. This portends that such tertiary hospitals that
insist on proper procedures of investigation and man-
agement outline are beyond the reach of low-income
earners. Hence, most parents patronise patent medi-
cine dealers/pharmacy shops, nursing homes and pri-
vate clinics that are usually less equipped and manned.
The issue of meeting with cost of drugs and other ser-
vices is a major obstacle to the success of home man-
agement of malaria in the roll back malaria programme
currently being embarked upon by the Nigerian gov-
ernment.
The increasing and widespread of malaria parasite to
low cost antimalaria drugs with minimal side effect in-
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preparations has led to a push to introduce combina-
tion therapies particularly those containing more ex-
pensive combination drugs including the artemisinin-
based derivatives which are over thirty times more
expensive than the older drugs. The recent decision
by the Nigerian government to subsidise artemisinin
for paediatric malaria treatment is a step in the right
direction. However, the Nigerian government is
currently contemplating a ban on chloroquine-
based antimalarial, this does not seem to be a pos-
sible solution to malaria resistance as substandard
quality and dosage contributed immensely to its in-
effectiveness as an antimalarial. The activities of
National Food and Drugs Administration and Con-
trol (NAFDAC) are currently combating the sales
of substandard and fake brands in the Nigerian
market.
A combination of chloroquine and sulphadoxine/py-
rimethamine preparations seem to be succeeding in
malaria management in the study area. This, how-
ever, requires proper dosing and management by
trained health officers as improper dosing was no-
ticed as the major cause of treatment failure at the
family levels. Despite reported cases of treatment
failures in some parts of the world, the Chinese
herbal drugs Artemisinin and Artemether are highly
effective in the study area. An additional advantage
of these drugs was that their use did not seem to
result in increase of serum fibrinogen concentra-
tions, as is the case with the chloroquine, py-
rimethamine/sulphadoxine and the amodiaquine.
This, however, requires further studies on its mode
of action and effect on  human rheology. The major
consideration in the choice of therapeutic agents for
the management of malaria in the study was at
higher cost. This underlines the need for effective
and less expensive drugs for malaria management in
Nigeria and tropical Africa in general. The eco-
nomic cost of malaria to sub-Saharan Africa is
enormous, and external efforts and cooperation of
donor agencies are required to find a solution to
this great killer of our time.
Acknowledgement
The authors are grateful to the staff of children emer-
gency, pharmacy and pathology departments of Abia
State University Teaching Hospital, Aba.  We are
particular indebted to Mr. C.O. Emuchuay of the
haematology and blood transfusion departments for
his assistance and criticisms in the course of this
study.
References
1. WHO expert committee on malaria. XX Tech Rep Ser No.
892;  2002: 32.
2. Stanley  S.  Emergence. Med Clin North Am 1997 15(1):
113 – 5.
3. Etuk EU, Umoh UF.  The evaluation of some commercially
available oral preparations of chloroquine in Sokoto urban.
J Life  Environ Sci 2001; 2(3):  103–7.
4. White NJ. Malaria. In :  Cook GC editor. Manson’s tropical
diseases. XX edn. London: WB Saunders 1996; p. 1087–
1164.
5. Nigeria supports roll back malaria movement. September
Newsletter. Abuja: WHO 1999; p. 2.
6. Roll back malaria. March Newsletter. Lagos: UNICEF 1999;
p. 5.
7. Bruce-Chwatt LJ.  Essential malariology. II edn. London:
William Heinemann Medical Books 1985; p. 265.
8. Olsen I, Magnussen P, Onuma JH, Andraessen J, Frilis H.
The contribution of hookworm and other parasitic
infections to haemoglobin and iron status among children
and adults in western Kenya. Trans R Soc Trop Med Hyg
1989;  92:  643–9.
9. Bain BJ.  Basic haematological techniques. In: Dacie JV,
Lewis SM editors. Practical haematology. VIII edn.
London: Churchill Livingstone1994; p. 57–60.
10. Mackie TJ, MacCartney JE. Practical medical microbiol-
ogy. London: Churchill Livingstone 1989; p. 457–78.
11. Stokes EJ, Ridgwey GL.  Clinical bacteriology. V edn.
London: Arnold 1980; p. 33.
12. Muller RH. Worms and disease. A manual of medical
helminthology. London: Butler and Tanner Ltd, William
Heinemann Medical Books 1975; p. 167.J  VECT  BORNE  DIS  42, SEPTEMBER  2005 94
13. Manual and procedures for clinical reagents. IV edn.
Antrim N.  Ireland: Randox Laboratories Ltd. 2001;
p. 13–6.
14. Salako LA.  In: Alfred C. Buck editor. USAID: Malaria
problems in Africa. III series of regional conferences on
the development and clinical evaluation of potential
malaria vaccines 1997; p. 131–40.
15. Salum  FM, Wilkes TJ, Kwunbi K, Curtis CF. Mortality of
under-fives in a rural area of holoendemic malaria
transmission. Acta Tropica 1994; 58:  29–34.
Corresponding author: Dr. G.R.A. Okogun, Department of Medical Laboratory Sciences, College of Medicine,
P.M.B. 14, Ekpoma, Edo State, Nigeria
e-mail: graokogun@yahoo.com